According to Intercept Pharmaceuticals 's latest financial reports the company's total debt is $0.22 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $0.33 B | -39.21% |
2021-12-31 | $0.54 B | -4.92% |
2020-12-31 | $0.57 B | 6.87% |
2019-12-31 | $0.53 B | 45.06% |
2018-12-31 | $0.37 B | 4.38% |
2017-12-31 | $0.35 B | 4.2% |
2016-12-31 | $0.34 B | |
2012-12-31 | $N/A | -100% |
2011-12-31 | $0.08 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $25.22 B | 11,168.54% | ๐บ๐ธ USA |
Gilead Sciences GILD | $24.98 B | 11,062.09% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $41.46 B | 18,422.62% | ๐บ๐ธ USA |
MediciNova MNOV | $0.21 M | -99.90% | ๐บ๐ธ USA |